---
title: "Akeso grants 3,603,500 share options at HK$ 99.5 exercise price under employee incentive plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293845089.md"
description: "Akeso granted 3,603,500 share options at HK$99.5 exercise price and 1,648,500 restricted share units to employees on July 24, 2026. The options have a 10-year validity with mixed or performance-based vesting up to 48 months. The RSUs were granted at nil purchase price with similar vesting schedules. Both awards include clawback provisions."
datetime: "2026-07-26T11:52:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293845089.md)
  - [en](https://longbridge.com/en/news/293845089.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293845089.md)
generator: "portal-rs"
---

# Akeso grants 3,603,500 share options at HK$ 99.5 exercise price under employee incentive plan

-   Akeso granted 3,603,500 share options on July 24, 2026 to 167 directors, executives, and employees. \* Options carry an exercise price of HK$ 99.5 per share; validity set at 10 years from grant date. \* A further 1,648,500 restricted share units were granted the same day to 162 recipients; purchase price set at nil. \* Both awards use mixed vesting schedules up to 48 months, or performance-based vesting; awards include clawback provisions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akeso Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260726-12256645), on July 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [09926.HK](https://longbridge.com/en/quote/09926.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [SDIC Securities Reaffirms Their Buy Rating on Akeso, Inc. (9926)](https://longbridge.com/en/news/298124424.md)
- [Daiwa Slightly Raises Confidence in Success of Global First-line NSCLC Phase III Trial OS After AKESO  HARMONi-2 Interim OS Analysis Meets Target](https://longbridge.com/en/news/297985739.md)
- [Akeso, Summit cancer drug confirms lung cancer survival benefit](https://longbridge.com/en/news/298059867.md)
- [Akeso Grants New Share Options to Boost Long-Term Incentives](https://longbridge.com/en/news/293845400.md)
- [Summit Therapeutics strengthened by positive ivonescimab survival results](https://longbridge.com/en/news/297927190.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**